Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-10-16

AUTHORS

P Martin, N Bleyzac, G Souillet, C Galambrun, Y Bertrand, P H Maire, R W Jelliffe, G Aulagner

ABSTRACT

Summary:The aim of this study was to identify the risk factors for acute graft-versus-host disease (aGVHD) in children transplanted from a matched-sibling donor (MSD) or an unrelated donor (UD). In all, 87 children consecutively underwent allogeneic bone marrow transplantation (BMT) from MSD (n=36), and UD (n=51). GVHD prophylaxis included CsA alone (n=33) or with MTX (n=51). ATG was added in UD-BMT and thalassemic recipients. CsA whole-blood concentrations were measured by EMIT and the dosing regimen was monitored by Bayesian pharmacokinetic modelling. Trough blood concentration (TBC) during the first 2 weeks post transplantation was lower in children who developed grade II–IV aGVHD than those developing no GVHD or only grade I (57±9 vs 94±8 ng/ml, P=0.007), whereas peak blood concentration and area under concentration curve vs time were similar in both groups. TBC <85 ng/ml and ‘use of MTX’ were associated with aGVHD in MSD-SCT (P=0.003 and 0.007, respectively) as well as in UD-SCT (P=0.006 and 0.003). Donor age ⩾8 years was significant only in MSD-BMT. Our results have shown the significant decisive role of pharmacological factors such as CSA TBC or use of MTX in the occurrence of GVHD in MSD as well as in UD paediatric BMT. More... »

PAGES

881-887

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bmt.1704239

DOI

http://dx.doi.org/10.1038/sj.bmt.1704239

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1002246124

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/14561988


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Area Under Curve", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bayes Theorem", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclosporine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Monitoring", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graft vs Host Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Histocompatibility", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Incidence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methotrexate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Donors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Debrousse Hospital, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.413959.3", 
          "name": [
            "Department of Pharmacy, Debrousse Hospital, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Martin", 
        "givenName": "P", 
        "id": "sg:person.01254462007.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254462007.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "ADCAPT, A Charial Hospital, Francheville, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Pharmacy, Debrousse Hospital, Lyon, France", 
            "ADCAPT, A Charial Hospital, Francheville, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bleyzac", 
        "givenName": "N", 
        "id": "sg:person.01250741512.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250741512.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.413959.3", 
          "name": [
            "Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Souillet", 
        "givenName": "G", 
        "id": "sg:person.0740146060.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740146060.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.413959.3", 
          "name": [
            "Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Galambrun", 
        "givenName": "C", 
        "id": "sg:person.0636145504.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636145504.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.413959.3", 
          "name": [
            "Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bertrand", 
        "givenName": "Y", 
        "id": "sg:person.01077622701.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077622701.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "ADCAPT, A Charial Hospital, Francheville, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "ADCAPT, A Charial Hospital, Francheville, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maire", 
        "givenName": "P H", 
        "id": "sg:person.01034324775.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034324775.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Applied Pharmacokinetics, University of Southern California, School of Medicine, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "Laboratory of Applied Pharmacokinetics, University of Southern California, School of Medicine, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jelliffe", 
        "givenName": "R W", 
        "id": "sg:person.011710475215.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011710475215.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Faculty of Pharmacy, University H Poincar\u00e9, Nancy, France", 
          "id": "http://www.grid.ac/institutes/grid.29172.3f", 
          "name": [
            "Department of Pharmacy, Debrousse Hospital, Lyon, France", 
            "Faculty of Pharmacy, University H Poincar\u00e9, Nancy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aulagner", 
        "givenName": "G", 
        "id": "sg:person.075614563.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.075614563.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bmt.1702460", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035839342", 
          "https://doi.org/10.1038/sj.bmt.1702460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1702868", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024488164", 
          "https://doi.org/10.1038/sj.bmt.1702868"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-10-16", 
    "datePublishedReg": "2003-10-16", 
    "description": "Summary:The aim of this study was to identify the risk factors for acute graft-versus-host disease (aGVHD) in children transplanted from a matched-sibling donor (MSD) or an unrelated donor (UD). In all, 87 children consecutively underwent allogeneic bone marrow transplantation (BMT) from MSD (n=36), and UD (n=51). GVHD prophylaxis included CsA alone (n=33) or with MTX (n=51). ATG was added in UD-BMT and thalassemic recipients. CsA whole-blood concentrations were measured by EMIT and the dosing regimen was monitored by Bayesian pharmacokinetic modelling. Trough blood concentration (TBC) during the first 2 weeks post transplantation was lower in children who developed grade II\u2013IV aGVHD than those developing no GVHD or only grade I (57\u00b19 vs 94\u00b18\u2009ng/ml, P=0.007), whereas peak blood concentration and area under concentration curve vs time were similar in both groups. TBC <85\u2009ng/ml and \u2018use of MTX\u2019 were associated with aGVHD in MSD-SCT (P=0.003 and 0.007, respectively) as well as in UD-SCT (P=0.006 and 0.003). Donor age \u2a7e8 years was significant only in MSD-BMT. Our results have shown the significant decisive role of pharmacological factors such as CSA TBC or use of MTX in the occurrence of GVHD in MSD as well as in UD paediatric BMT.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bmt.1704239", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "32"
      }
    ], 
    "keywords": [
      "matched-sibling donor", 
      "trough blood concentrations", 
      "bone marrow transplantation", 
      "pediatric bone marrow transplantation", 
      "use of MTX", 
      "unrelated donors", 
      "acute graft", 
      "host disease", 
      "marrow transplantation", 
      "risk factors", 
      "blood concentrations", 
      "CsA trough blood concentrations", 
      "allogeneic bone marrow transplantation", 
      "only grade I", 
      "occurrence of GVHD", 
      "pharmacological risk factors", 
      "peak blood concentration", 
      "weeks post transplantation", 
      "whole blood concentrations", 
      "GVHD prophylaxis", 
      "UD-BMT", 
      "MSD-SCT", 
      "UD-SCT", 
      "MSD-BMT", 
      "post transplantation", 
      "grade II", 
      "grade I", 
      "donor age", 
      "pharmacological factors", 
      "pharmacokinetic modelling", 
      "transplantation", 
      "MTX", 
      "aGVHD", 
      "GVHD", 
      "graft", 
      "disease", 
      "children", 
      "concentration curve", 
      "donors", 
      "prophylaxis", 
      "regimen", 
      "factors", 
      "recipients", 
      "CsA", 
      "age", 
      "concentration", 
      "group", 
      "aim", 
      "years", 
      "use", 
      "study", 
      "role", 
      "ATG", 
      "occurrence", 
      "time", 
      "curves", 
      "decisive role", 
      "area", 
      "results", 
      "emits", 
      "modelling"
    ], 
    "name": "Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors", 
    "pagination": "881-887", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1002246124"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bmt.1704239"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "14561988"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bmt.1704239", 
      "https://app.dimensions.ai/details/publication/pub.1002246124"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_371.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bmt.1704239"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704239'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704239'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704239'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704239'


 

This table displays all metadata directly associated to this object as RDF triples.

268 TRIPLES      21 PREDICATES      107 URIs      97 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bmt.1704239 schema:about N32484b9b2fd74e778504dc6c6c115f97
2 N3c6da7076e4f4c878b3525e182ebcac8
3 N3e7f2584f23748c1b5c823d3f72359dd
4 N4da5362754aa491d99537fdd7bcb9829
5 N4ff6c33dda304b06a9b58f1c8c6cc3e6
6 N54eab3efeddc4ed79a042e6ce3d8451d
7 N57e1947ce2e54e5fa4e43b32770816e7
8 N64c287ec79a04df191bf22ef9b5d8a10
9 N7450e02526e14a8293d2e119ba4b0e21
10 N7bb8455d6879483d9e78b16ef3b02002
11 N853b57fa7ec84fd7b5032523a252f47c
12 N8b1bae3aa92445fb8c64e8e97a043dd9
13 N8d046b76e1c541bbba0162c1c30b4634
14 N96665b6e33354247b7dd5202b27f24e3
15 Nb933880678934512a7613d864cfc169b
16 Nc239ff2de58240b8a119bdb96ad1129d
17 Nc677626b5b744fc1b1b472b2f6db1189
18 Nd6081ccae6024afabf3ec3d081693027
19 Nfd56f0ee70f84c24b09d1aa83e6fdc84
20 anzsrc-for:11
21 anzsrc-for:1102
22 schema:author N4253467aebdc47288fdd7fe7135f2b75
23 schema:citation sg:pub.10.1038/sj.bmt.1702460
24 sg:pub.10.1038/sj.bmt.1702868
25 schema:datePublished 2003-10-16
26 schema:datePublishedReg 2003-10-16
27 schema:description Summary:The aim of this study was to identify the risk factors for acute graft-versus-host disease (aGVHD) in children transplanted from a matched-sibling donor (MSD) or an unrelated donor (UD). In all, 87 children consecutively underwent allogeneic bone marrow transplantation (BMT) from MSD (n=36), and UD (n=51). GVHD prophylaxis included CsA alone (n=33) or with MTX (n=51). ATG was added in UD-BMT and thalassemic recipients. CsA whole-blood concentrations were measured by EMIT and the dosing regimen was monitored by Bayesian pharmacokinetic modelling. Trough blood concentration (TBC) during the first 2 weeks post transplantation was lower in children who developed grade II–IV aGVHD than those developing no GVHD or only grade I (57±9 vs 94±8 ng/ml, P=0.007), whereas peak blood concentration and area under concentration curve vs time were similar in both groups. TBC <85 ng/ml and ‘use of MTX’ were associated with aGVHD in MSD-SCT (P=0.003 and 0.007, respectively) as well as in UD-SCT (P=0.006 and 0.003). Donor age ⩾8 years was significant only in MSD-BMT. Our results have shown the significant decisive role of pharmacological factors such as CSA TBC or use of MTX in the occurrence of GVHD in MSD as well as in UD paediatric BMT.
28 schema:genre article
29 schema:isAccessibleForFree false
30 schema:isPartOf N7b3457f0c7534ca3abaccf8055a691e5
31 Nd6a6d10465714929bbb6829607aafd5f
32 sg:journal.1096890
33 schema:keywords ATG
34 CsA
35 CsA trough blood concentrations
36 GVHD
37 GVHD prophylaxis
38 MSD-BMT
39 MSD-SCT
40 MTX
41 UD-BMT
42 UD-SCT
43 aGVHD
44 acute graft
45 age
46 aim
47 allogeneic bone marrow transplantation
48 area
49 blood concentrations
50 bone marrow transplantation
51 children
52 concentration
53 concentration curve
54 curves
55 decisive role
56 disease
57 donor age
58 donors
59 emits
60 factors
61 grade I
62 grade II
63 graft
64 group
65 host disease
66 marrow transplantation
67 matched-sibling donor
68 modelling
69 occurrence
70 occurrence of GVHD
71 only grade I
72 peak blood concentration
73 pediatric bone marrow transplantation
74 pharmacokinetic modelling
75 pharmacological factors
76 pharmacological risk factors
77 post transplantation
78 prophylaxis
79 recipients
80 regimen
81 results
82 risk factors
83 role
84 study
85 time
86 transplantation
87 trough blood concentrations
88 unrelated donors
89 use
90 use of MTX
91 weeks post transplantation
92 whole blood concentrations
93 years
94 schema:name Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors
95 schema:pagination 881-887
96 schema:productId N17a985856aeb451cbeaf9405d13c960f
97 N968002d867334709a31b6878a3f8d8a9
98 Na11b23fb470448df9af3e95af6274b69
99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002246124
100 https://doi.org/10.1038/sj.bmt.1704239
101 schema:sdDatePublished 2022-12-01T06:23
102 schema:sdLicense https://scigraph.springernature.com/explorer/license/
103 schema:sdPublisher N7492f291a09c4a9b9a3f096080800ca3
104 schema:url https://doi.org/10.1038/sj.bmt.1704239
105 sgo:license sg:explorer/license/
106 sgo:sdDataset articles
107 rdf:type schema:ScholarlyArticle
108 N0ab6db7a48754d4d99fcc42ee38a2e03 rdf:first sg:person.0636145504.03
109 rdf:rest Nc70d8bfbc3fc4a34813c78f676f6da6c
110 N17a985856aeb451cbeaf9405d13c960f schema:name dimensions_id
111 schema:value pub.1002246124
112 rdf:type schema:PropertyValue
113 N32484b9b2fd74e778504dc6c6c115f97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Bone Marrow Transplantation
115 rdf:type schema:DefinedTerm
116 N3c6da7076e4f4c878b3525e182ebcac8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Bayes Theorem
118 rdf:type schema:DefinedTerm
119 N3c92c2001a4e48f5a0953f0a0711d830 rdf:first sg:person.011710475215.90
120 rdf:rest Nda451eb4a7584cc0936a6bf5aa84d535
121 N3e7f2584f23748c1b5c823d3f72359dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Histocompatibility
123 rdf:type schema:DefinedTerm
124 N4253467aebdc47288fdd7fe7135f2b75 rdf:first sg:person.01254462007.47
125 rdf:rest Ncbe0ccc01822426089a944b630ce7bdd
126 N4da5362754aa491d99537fdd7bcb9829 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Child
128 rdf:type schema:DefinedTerm
129 N4ff6c33dda304b06a9b58f1c8c6cc3e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Cyclosporine
131 rdf:type schema:DefinedTerm
132 N54eab3efeddc4ed79a042e6ce3d8451d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Incidence
134 rdf:type schema:DefinedTerm
135 N57e1947ce2e54e5fa4e43b32770816e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Child, Preschool
137 rdf:type schema:DefinedTerm
138 N64c287ec79a04df191bf22ef9b5d8a10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Female
140 rdf:type schema:DefinedTerm
141 N719b85ef81b3439cadfea4f1a0f652c5 rdf:first sg:person.01034324775.43
142 rdf:rest N3c92c2001a4e48f5a0953f0a0711d830
143 N7450e02526e14a8293d2e119ba4b0e21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Drug Monitoring
145 rdf:type schema:DefinedTerm
146 N7492f291a09c4a9b9a3f096080800ca3 schema:name Springer Nature - SN SciGraph project
147 rdf:type schema:Organization
148 N77df0d04dc604af3ab998e0b1fa0a90d rdf:first sg:person.0740146060.37
149 rdf:rest N0ab6db7a48754d4d99fcc42ee38a2e03
150 N7b3457f0c7534ca3abaccf8055a691e5 schema:volumeNumber 32
151 rdf:type schema:PublicationVolume
152 N7bb8455d6879483d9e78b16ef3b02002 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Acute Disease
154 rdf:type schema:DefinedTerm
155 N853b57fa7ec84fd7b5032523a252f47c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Humans
157 rdf:type schema:DefinedTerm
158 N8b1bae3aa92445fb8c64e8e97a043dd9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Male
160 rdf:type schema:DefinedTerm
161 N8d046b76e1c541bbba0162c1c30b4634 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Graft vs Host Disease
163 rdf:type schema:DefinedTerm
164 N96665b6e33354247b7dd5202b27f24e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Adolescent
166 rdf:type schema:DefinedTerm
167 N968002d867334709a31b6878a3f8d8a9 schema:name doi
168 schema:value 10.1038/sj.bmt.1704239
169 rdf:type schema:PropertyValue
170 Na11b23fb470448df9af3e95af6274b69 schema:name pubmed_id
171 schema:value 14561988
172 rdf:type schema:PropertyValue
173 Nb933880678934512a7613d864cfc169b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Methotrexate
175 rdf:type schema:DefinedTerm
176 Nc239ff2de58240b8a119bdb96ad1129d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Tissue Donors
178 rdf:type schema:DefinedTerm
179 Nc677626b5b744fc1b1b472b2f6db1189 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Area Under Curve
181 rdf:type schema:DefinedTerm
182 Nc70d8bfbc3fc4a34813c78f676f6da6c rdf:first sg:person.01077622701.25
183 rdf:rest N719b85ef81b3439cadfea4f1a0f652c5
184 Ncbe0ccc01822426089a944b630ce7bdd rdf:first sg:person.01250741512.98
185 rdf:rest N77df0d04dc604af3ab998e0b1fa0a90d
186 Nd6081ccae6024afabf3ec3d081693027 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Infant
188 rdf:type schema:DefinedTerm
189 Nd6a6d10465714929bbb6829607aafd5f schema:issueNumber 9
190 rdf:type schema:PublicationIssue
191 Nda451eb4a7584cc0936a6bf5aa84d535 rdf:first sg:person.075614563.37
192 rdf:rest rdf:nil
193 Nfd56f0ee70f84c24b09d1aa83e6fdc84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Risk Factors
195 rdf:type schema:DefinedTerm
196 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
197 schema:name Medical and Health Sciences
198 rdf:type schema:DefinedTerm
199 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
200 schema:name Cardiorespiratory Medicine and Haematology
201 rdf:type schema:DefinedTerm
202 sg:journal.1096890 schema:issn 0268-3369
203 1476-5365
204 schema:name Bone Marrow Transplantation
205 schema:publisher Springer Nature
206 rdf:type schema:Periodical
207 sg:person.01034324775.43 schema:affiliation grid-institutes:None
208 schema:familyName Maire
209 schema:givenName P H
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034324775.43
211 rdf:type schema:Person
212 sg:person.01077622701.25 schema:affiliation grid-institutes:grid.413959.3
213 schema:familyName Bertrand
214 schema:givenName Y
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077622701.25
216 rdf:type schema:Person
217 sg:person.011710475215.90 schema:affiliation grid-institutes:grid.42505.36
218 schema:familyName Jelliffe
219 schema:givenName R W
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011710475215.90
221 rdf:type schema:Person
222 sg:person.01250741512.98 schema:affiliation grid-institutes:None
223 schema:familyName Bleyzac
224 schema:givenName N
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250741512.98
226 rdf:type schema:Person
227 sg:person.01254462007.47 schema:affiliation grid-institutes:grid.413959.3
228 schema:familyName Martin
229 schema:givenName P
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254462007.47
231 rdf:type schema:Person
232 sg:person.0636145504.03 schema:affiliation grid-institutes:grid.413959.3
233 schema:familyName Galambrun
234 schema:givenName C
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636145504.03
236 rdf:type schema:Person
237 sg:person.0740146060.37 schema:affiliation grid-institutes:grid.413959.3
238 schema:familyName Souillet
239 schema:givenName G
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740146060.37
241 rdf:type schema:Person
242 sg:person.075614563.37 schema:affiliation grid-institutes:grid.29172.3f
243 schema:familyName Aulagner
244 schema:givenName G
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.075614563.37
246 rdf:type schema:Person
247 sg:pub.10.1038/sj.bmt.1702460 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035839342
248 https://doi.org/10.1038/sj.bmt.1702460
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/sj.bmt.1702868 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024488164
251 https://doi.org/10.1038/sj.bmt.1702868
252 rdf:type schema:CreativeWork
253 grid-institutes:None schema:alternateName ADCAPT, A Charial Hospital, Francheville, France
254 schema:name ADCAPT, A Charial Hospital, Francheville, France
255 Department of Pharmacy, Debrousse Hospital, Lyon, France
256 rdf:type schema:Organization
257 grid-institutes:grid.29172.3f schema:alternateName Faculty of Pharmacy, University H Poincaré, Nancy, France
258 schema:name Department of Pharmacy, Debrousse Hospital, Lyon, France
259 Faculty of Pharmacy, University H Poincaré, Nancy, France
260 rdf:type schema:Organization
261 grid-institutes:grid.413959.3 schema:alternateName Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France
262 Department of Pharmacy, Debrousse Hospital, Lyon, France
263 schema:name Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France
264 Department of Pharmacy, Debrousse Hospital, Lyon, France
265 rdf:type schema:Organization
266 grid-institutes:grid.42505.36 schema:alternateName Laboratory of Applied Pharmacokinetics, University of Southern California, School of Medicine, Los Angeles, CA, USA
267 schema:name Laboratory of Applied Pharmacokinetics, University of Southern California, School of Medicine, Los Angeles, CA, USA
268 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...